Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Duchenne muscular dystrophy (DMD) is a lethal, X-linked disease that causes severe loss of muscle mass and function in young children. Promising therapies for DMD are being developed, but the long lead times required when using clinical outcome measures are hindering progress. This progress would be...
Saved in:
Main Authors: | Miranda D. Grounds (Author), Jessica R. Terrill (Author), Basma A. Al-Mshhdani (Author), Marisa N. Duong (Author), Hannah G. Radley-Crabb (Author), Peter G. Arthur (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
by: Basma A. Al-Mshhdani, et al.
Published: (2021) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995) -
Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013)